Described is a nucleic acid molecule comprising (a) a nucleic acid sequence encoding the monocyte-chemoattractant-protein-1 (MCP-1) or a protein having the biological activity of the monocyte-chemoattractant-protein-1 (MCP-1) and (b) a hypersensitivity region. Also described are pharmaceutical compositions for the treatment of diseases associated with dysregulation of MCP-1 expression, e.g. atherosclerosis or cancer. <IMAGE>
申请公布号
EP1170372(B1)
申请公布日期
2006.04.19
申请号
EP20000114560
申请日期
2000.07.06
申请人
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS
发明人
ROESL, DR. FRANK;SOTO, DR. UBALDO;COY, DR. JOHANNES;FINZER, DR. PATRICK;DELIUS, DR. HAJO;POUSTKA, PROF. ANNEMARIE;ZUR HAUSEN, HARALD DR;PATZELT, ANDREA